Alecensaro (alectinib)

pCPA File Number: 21039

Negotiation Status:

Concluded with an LOI

Indication(s):

Locally advanced or metastatic non-small cell lung cancer

Sponsor/Manufacturer:

Hoffmann-La Roche

CADTH Project Number:

pCODR 10114

pCPA Engagement Letter Issued:

2018-09-07

Negotiation Process Concluded:

2018-12-11